NeuroPace, Inc.
NPCE
$11.26
$0.110.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.93% | 9.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.93% | 9.37% | |||
| Cost of Revenue | -6.42% | 10.11% | |||
| Gross Profit | 4.98% | 9.10% | |||
| SG&A Expenses | -0.85% | -2.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.73% | -0.72% | |||
| Operating Income | 13.91% | 31.89% | |||
| Income Before Tax | 3.71% | 27.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.71% | 27.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.71% | 27.44% | |||
| EBIT | 13.91% | 31.89% | |||
| EBITDA | 13.90% | 32.16% | |||
| EPS Basic | 5.24% | 28.88% | |||
| Normalized Basic EPS | 1.04% | 28.93% | |||
| EPS Diluted | 5.24% | 28.88% | |||
| Normalized Diluted EPS | 1.04% | 28.93% | |||
| Average Basic Shares Outstanding | 1.60% | 2.05% | |||
| Average Diluted Shares Outstanding | 1.60% | 2.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||